GLP-1 Science
Semaglutide vs. Tirzepatide: Which Is Right for You?
This is the most common question we get, and the honest answer is that both work extremely well. The differences are real, though, and they matter more for some people than others. Here is everything you need to weigh it up.
8 min read · Updated · Published by CoreAge Rx
The mechanical difference
Semaglutide is a single-agonist: it activates one receptor, the GLP-1 receptor. Tirzepatide is a dual agonist: it activates the GLP-1 receptor *and* the GIP receptor. GIP is a second incretin hormone, and adding it appears to do two useful things — improve how fat tissue stores and releases energy, and blunt the nausea signalling that GLP-1 activation alone can produce.
If the underlying biology is new to you, The Complete Guide to GLP-1 Medications explains the whole incretin system from the ground up. If the brand names are what is confusing you, the two pairs are unpicked in Ozempic vs. Wegovy: Same Drug, Different Label and Mounjaro vs. Zepbound: Same Drug, Different Label.
Head to head
| Semaglutide | Tirzepatide | |
|---|---|---|
| Receptors | GLP-1 | GLP-1 + GIP |
| Brand equivalents | Ozempic, Wegovy | Mounjaro, Zepbound |
| Mean weight loss (trial) | 14.9% at 68 weeks | 20.9% at 72 weeks |
| Reached 20%+ loss | About 1 in 3 | About 4 in 7 |
| Dose range | 0.25 → 2.4 mg weekly | 2.5 → 15 mg weekly |
| Titration steps | 5 steps, roughly monthly | 6 steps, roughly monthly |
| Nausea rate in trials | ~44% | ~29% at comparable doses |
| Cardiovascular outcome data | Yes — SELECT, 20% MACE reduction | Trials ongoing |
| In use since | 2017 (diabetes), 2021 (weight) | 2022 |
| Relative cost | Lower | Higher |
The case for tirzepatide
- More weight loss, on average. In SURMOUNT-1, the 15 mg group averaged 20.9% of body weight over 72 weeks — the largest result any weight medication has produced in a trial of that size.
- Often gentler than expected. Despite being more powerful, reported nausea rates were lower than semaglutide's at comparable effect. The GIP component is the leading explanation.
- Better numbers for blood sugar. Head-to-head in type 2 diabetes (SURPASS-2), tirzepatide beat semaglutide on both HbA1c and weight.
- More room to move. Six dose steps up to 15 mg gives your physician finer control if progress stalls — see GLP-1 Dosing and Titration, Week by Week.
The case for semaglutide
- The longest track record. In clinical use since 2017 and studied in tens of thousands of patients. When you want the most thoroughly mapped option, this is it.
- Proven heart benefit. SELECT enrolled 17,604 people with heart disease and no diabetes, and found a 20% reduction in heart attack, stroke and cardiovascular death. No other weight medication has that evidence yet. GLP-1 Benefits Beyond the Scale goes into what that means day to day.
- More affordable. Consistently the lower-cost option, which matters if you are planning for a year or more. Full pricing in What GLP-1 Medication Costs in 2026.
- Plenty strong enough. 15% of body weight is life-changing. For a great many people, semaglutide comfortably clears the goal they actually have.
Not sure which to choose? That is what the consult is for.
Tell us your history and goals. A US board-certified physician recommends the option that fits — and adjusts it later if needed.
Get Started Now →✓ Starts at $99/month ✓ No insurance required ✓ Free 2-day shipping ✓ 24-hour approval
Which tends to suit whom
You have 50+ lb to lose
Tirzepatide's higher average result and wider dose range give more headroom for a large goal.
Cost is the deciding factor
Semaglutide delivers most of the benefit at a meaningfully lower monthly price.
You have heart disease
Semaglutide is the one with published cardiovascular outcome data behind it. Say so during your consultation.
You have a sensitive stomach
Tirzepatide's lower nausea rates are a genuine advantage — though Managing GLP-1 Side Effects helps either way.
You also have type 2 diabetes
Tirzepatide outperformed semaglutide on blood sugar head-to-head. Both are strong; one is stronger.
You are starting from scratch
Semaglutide is the standard first step for good reason: predictable, well-mapped, and easy to switch from later.
Can you switch?
Yes, and it is routine. Plenty of patients start on semaglutide, reach a plateau in month six or seven, and move to tirzepatide to restart progress. Your physician will restart the titration ladder rather than matching dose for dose — the two are not interchangeable milligram for milligram. Switching is a clinical decision, never a self-directed one.
Common questions
Is tirzepatide simply better?
On average it produces more weight loss. But 'average' hides enormous individual variation — some people respond far better to semaglutide than the averages predict. Both are excellent; the right one is the one that works for your body and your budget.
Does CoreAge Rx offer both?
Yes. Both compounded semaglutide and compounded tirzepatide are available, and your physician recommends between them. See our reviews and pricing overview.
What is the difference from Ozempic or Mounjaro?
Same active ingredients. The difference is who prepares them and how they are supplied — explained fully in Compounded GLP-1 Medication, Explained.
Can I take both at once?
No. They act on overlapping receptors and stacking them raises side-effect risk with no established benefit. One at a time, always.
Start with a plan, not a guess
Complete the assessment in five minutes and let a physician recommend your starting point.
Get Started Now →✓ Starts at $99/month ✓ No insurance required ✓ Free 2-day shipping ✓ 24-hour approval